Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Napco Security Technologies
NSSC
$1.37B
| $8.08M | ﹤0.01% |
235,900
+5,723
| +2% | +$152K |
|
2102
Amneal Pharmaceuticals
AMRX
$6.02B
| $8.07M | ﹤0.01% |
1,329,508
+26,875
| +2% | +$120K |
|
2103
CRA International
CRAI
$1.07B
| $8.06M | ﹤0.01% |
81,514
+8,907
| +12% | +$864K |
|
2104
Kearny Financial
KRNY
$604M
| $8.05M | ﹤0.01% |
897,523
+34,443
| +4% | +$267K |
|
2105
Origin Bancorp
OBK
$1.69B
| $8.05M | ﹤0.01% |
226,304
+2,769
| +1% | +$87.8K |
|
2106
Mercantile Bank Corp
MBWM
$1.06B
| $8.04M | ﹤0.01% |
199,041
+3,232
| +2% | +$113K |
|
2107
Cytek Biosciences
CTKB
$636M
| $8.03M | ﹤0.01% |
880,038
+44,345
| +5% | +$279K |
|
2108
MacroGenics
MGNX
$259M
| $8.02M | ﹤0.01% |
833,500
+8,111
| +1% | +$56.1K |
|
2109
ZipRecruiter
ZIP
$388M
| $8.01M | ﹤0.01% |
576,218
+20,130
| +4% | +$249K |
|
2110
Resources Connection
RGP
$145M
| $8M | ﹤0.01% |
564,530
+29,253
| +5% | +$409K |
|
|
TRTX
2111
TPG RE Finance Trust
TRTX
$616M
| $8M | ﹤0.01% |
1,230,218
+108,106
| +10% | +$652K |
|
2112
Ameresco
AMRC
$1.47B
| $7.98M | ﹤0.01% |
252,083
+3,160
| +1% | +$95.3K |
|
2113
PDF Solutions
PDFS
$2.13B
| $7.97M | ﹤0.01% |
247,961
+6,999
| +3% | +$212K |
|
2114
DXP Enterprises
DXPE
$3B
| $7.9M | ﹤0.01% |
234,476
-9,606
| -4% | -$314K |
|
2115
Skyward Specialty Insurance
SKWD
$2.39B
| $7.88M | ﹤0.01% |
232,644
+30,746
| +15% | +$945K |
|
2116
Hertz
HTZ
$838M
| $7.88M | ﹤0.01% |
758,183
+22,251
| +3% | +$215K |
|
2117
Mirum Pharmaceuticals
MIRM
$6.02B
| $7.87M | ﹤0.01% |
266,681
+42,110
| +19% | +$1.27M |
|
2118
Titan International
TWI
$438M
| $7.84M | ﹤0.01% |
527,146
+1,927
| +0.4% | +$25.4K |
|
2119
Preferred Bank
PFBC
$1.28B
| $7.83M | ﹤0.01% |
107,233
-303
| -0.3% | -$19.7K |
|
2120
Dime Commercial Bancshares
DCOM
$1.82B
| $7.83M | ﹤0.01% |
290,838
+17,446
| +6% | +$374K |
|
2121
Kymera Therapeutics
KYMR
$9.51B
| $7.81M | ﹤0.01% |
306,692
+4,951
| +2% | +$88.5K |
|
|
PYCR
2122
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $7.81M | ﹤0.01% |
361,622
+7,965
| +2% | +$173K |
|
|
ARR
2123
Armour Residential REIT
ARR
$2.37B
| $7.73M | ﹤0.01% |
400,306
+38,746
| +11% | +$684K |
|
2124
Fulgent Genetics
FLGT
$513M
| $7.73M | ﹤0.01% |
267,313
+33,141
| +14% | +$887K |
|
|
BIG
2125
DELISTED
Big Lots, Inc.
BIG
| $7.71M | ﹤0.01% |
990,131
+284,258
| +40% | +$1.46M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.